收稿日期: 2020-04-27
网络出版日期: 2022-04-13
基金资助
国家自然科学基金(81230066);国家自然科学基金(81473043);国家自然科学基金(81703291);国家自然科学基金(81872695)
Incidence and risk factors of ischemic stroke in patients with type 2 diabetes among urban workers in Beijing, China
Received date: 2020-04-27
Online published: 2022-04-13
Supported by
National Natural Science Foundation of China(81230066);National Natural Science Foundation of China(81473043);National Natural Science Foundation of China(81703291);National Natural Science Foundation of China(81872695)
目的: 通过对新发2型糖尿病患者进行前瞻性观察,探究2型糖尿病发病后缺血性脑卒中的发病特点,并进一步分析2型糖尿病患者缺血性脑卒中发病的危险因素。方法: 数据资料来源于北京市城镇职工基本医疗保险信息系统数据库。研究采用前瞻性设计,对2010年新诊断为2型糖尿病的患者在2010—2017年缺血性脑卒中的发病情况进行描述,采用Logistic回归模型分析2型糖尿病患者缺血性脑卒中发病的危险因素。结果: 共纳入185 813例新发2型糖尿病患者,平均年龄(58.5±13.2)岁,男性占49.0%。随访7年内出现新发缺血性脑卒中患者10 393例,累积发病率为5.6%,发病密度为8.1/1 000人年。2型糖尿病患者缺血性脑卒中在各个年龄段均有发生,不同年龄组累积发病率分别为:≤44岁组1.5%(95%CI:1.3%~1.6%),45~54岁组3.6%(95%CI:3.4%~3.7%),55~64岁组5.4%(95%CI:5.2%~5.5%),≥65岁组9.2%(95%CI:9.0%~9.4%),累积发病率随年龄升高而增加(P<0.05)。男性累积发病率(6.8%,95%CI: 6.7%~7.0%)高于女性(4.4%,95%CI: 4.3%~4.6%);<80岁的患者中,男性在各年龄段累积发病率均高于女性;≥80岁的患者中,女性累积发病率(9.2%)高于男性(7.9%)。进一步分析2型糖尿病患者缺血性脑卒中发病的危险因素,发现患有冠心病(OR=3.18,95%CI:2.72~3.72)、心力衰竭(OR=1.53,95%CI:1.32~1.79)、肾衰竭(OR=1.45, 95%CI:1.20~1.75)等合并症与2型糖尿病患者缺血性脑卒中的发病有关。结论: 2型糖尿病患者缺血性脑卒中发病率仍处于较高水平,应针对老年患者加强危险因素管理,尽早筛查2型糖尿病患者的合并症情况并采取针对性的预防控制措施。
吴俊慧 , 武轶群 , 吴瑶 , 王紫荆 , 吴涛 , 秦雪英 , 王梦莹 , 王小文 , 王伽婷 , 胡永华 . 北京城镇职工2型糖尿病患者缺血性脑卒中发病率及主要危险因素[J]. 北京大学学报(医学版), 2022 , 54(2) : 249 -254 . DOI: 10.19723/j.issn.1671-167X.2022.02.008
Objective: To explore the incidence of ischemic stroke after the onset of type 2 diabetes, and further analyze the risk factors, so as to provide a basis for further research. Methods: The data were obtained from the database of the Beijing Urban Employee Basic Medical Insurance Database. The study used a prospective design to describe the incidence of ischemic stroke in patients with type 2 diabetes. In our study, these patients were followed up for seven years. Multivariate Logistic regression models were used to analyze the risk factors of ischemic stroke in patients with type 2 diabetes. Results: A total of 185 813 newly diagnosed type 2 diabetes patients were enrolled, with an average age of (58.5±13.2) years, and 49.0% of them were males. A total of 10 393 patients with newly diagnosed ischemic stroke occurred in 7 years, with a cumulative incidence of 5.6% and an incidence density of 8.1/1 000 person-years. Ischemic stroke occurred in all age groups in patients with type 2 diabetes. The cumulative incidence was 1.5% (95%CI: 1.3%-1.6%) in group ≤44 years old, 3.6% (95%CI: 3.4%-3.7%) in group 45-54 years old, 5.4% (95%CI: 5.2%-5.5%) in group 55-64 years old, and 9.2% (95%CI: 9.0%-9.4%) in group ≥65 years old, and the cumulative incidence increased with age (P<0.05). Cumulative incidence rate of the males (6.8%, 95%CI: 6.7%-7.0%) was higher than the females (4.4%, 95%CI: 4.3%-4.6%). Among the patients <80 years old, the cumulative incidence rate of the males was higher than that of the females in all the age groups. In the patients ≥80 years of age, the cumulative incidence was higher in the females (9.2%) than in the males (7.9%). Further analysis revealed that complications, such as coronary heart disease (OR=3.18, 95%CI: 2.72-3.72), heart failure (OR=1.53, 95%CI: 1.32-1.79) and kidney failure (OR=1.45, 95%CI: 1.20-1.75) were associated with ischemic stroke in the patients with type 2 diabetes. Conclusion: The incidence level of ischemic stroke in patients with type 2 diabetes is high. It is necessary to strengthen the management of risk factors in elderly patients, screen the complications of type 2 diabetes as early as possible, and take active preventive and control measures.
Key words: Diabetes mellitus; type 2; Stroke; Diabetes complication; Incidence
| [1] | Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: Glo-bal estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract, 2018, 138:271-281. |
| [2] | Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: A systema-tic analysis for the global burden of disease study 2013[J]. Lancet Neurol, 2016, 15(9):913-924. |
| [3] | Yang R, Pedersen NL, Bao C, et al. Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: A prospective nested case-control study in a nationwide Swedish twin cohort[J]. Diabetologia, 2019, 62(8):1403-1411. |
| [4] | Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: The greater Cincinnati/Northern Kentucky stroke study[J]. Diabetes Care, 2005, 28(2):355-359. |
| [5] | Huang ES, Laiteerapong N, Liu JY, et al. Rates of complications and mortality in older patients with diabetes mellitus: The diabetes and aging study[J]. JAMA Intern Med, 2014, 174(2):251-258. |
| [6] | Staszewsky L, Cortesi L, Baviera M, et al. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy[J]. Diabetes Res Clin Pract, 2015, 109(3):476-484. |
| [7] | Li J, Dong Y, Wu T, et al. Differences between Western and Asian type 2 diabetes patients in the incidence of vascular complications and mortality: A systematic review of randomized controlled trials on lowering blood glucose[J]. J Diabetes, 2016, 8(6):824-833. |
| [8] | Mulnier HE, Seaman HE, Raleigh VS, et al. Risk of stroke in people with type 2 diabetes in the UK: A study using the general practice research database[J]. Diabetologia, 2006, 49(12):2859-2865. |
| [9] | Giorda CB, Avogaro A, Maggini M, et al. Incidence and risk factors for stroke in type 2 diabetic patients: The DAI study[J]. Stroke, 2007, 38(4):1154-1160. |
| [10] | Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study[J]. Lancet Diabetes Endocrinol, 2019, 7(6):452-461. |
| [11] | Banerjee C, Moon YP, Paik MC, et al. Duration of diabetes and risk of ischemic stroke: The Northern Manhattan study[J]. Stroke, 2012, 43(5):1212-1217. |
| [12] | 任晓宇, 史典, 张德生, 等. 金昌队列人群代谢性疾病与脑卒中发病关系前瞻性研究[J]. 中华流行病学杂志, 2019, 40(5):521-525. |
| [13] | 沈卓之, 丁贤彬, 毛德强, 等. 2015年重庆市常住人口脑卒中发病与死亡情况[J]. 公共卫生与预防医学, 2016, 27(5):48-51. |
| [14] | 韩荣荣, 唐爱奇, 方杭燕, 等. 2型糖尿病患者并发脑卒中的前瞻性研究[J]. 预防医学, 2017, 29(2):139-141. |
| [15] | Luk AOY, Hui EMT, Sin MC, et al. Declining trends of cardiovascular-renal complications and mortality in type 2 diabetes: The Hong Kong diabetes database[J]. Diabetes Care, 2017, 40(7):928-935. |
| [16] | Shen Y, Shi L, Nauman E, et al. Race and sex differences in rates of diabetic complications[J]. J Diabetes, 2019, 11(6):449-456. |
| [17] | Wang Y, Dai Y, Zheng J, et al. Sex difference in the incidence of stroke and its corresponding influence factors: Results from a follow-up 8.4 years of rural China hypertensive prospective cohort study[J]. Lipids Health Dis, 2019, 18(1):72. |
| [18] | Barker-Collo S, Bennett DA, Krishnamurthi RV, et al. Sex diffe-rences in stroke incidence, prevalence, mortality and disability-adjusted life years: Results from the global burden of disease study 2013[J]. Neuroepidemiology, 2015, 45(3):203-214. |
| [19] | Madsen TE, Khoury JC, Alwell KA, et al. Sex differences in cardiovascular risk profiles of ischemic stroke patients with diabetes in the Greater Cincinnati/Northern Kentucky stroke study[J]. J Diabetes, 2018, 10(6):496-501. |
| [20] | Petrea RE, Beiser AS, Seshadri S, et al. Gender differences in stroke incidence and poststroke disability in the Framingham heart study[J]. Stroke, 2009, 40(4):1032-1037. |
| [21] | 申宏, 方旭东. 重庆市巴南区居民2012—2015年脑卒中发病情况分析[J]. 检验医学与临床, 2016, 13(23):3398-3399. |
| [22] | 叶虹. 2型糖尿病合并缺血性脑血管病的相关危险因素研究[D]. 广州: 南方医科大学, 2011. |
| [23] | GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: A systematic analysis for the glo-bal burden of disease study 2016[J]. Lancet Neurol, 2019, 18(5):439-458. |
| [24] | Madan S. Changes in diabetes-related complications in the United States[J]. N Engl J Med, 2014, 371(3):285-286. |
| [25] | Bui HDT, Jing X, Lu R, et al. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: A cross-sectional study[J]. Ann Transl Med, 2019, 7(14):325. |
/
| 〈 |
|
〉 |